688236 春立医疗
已收盘 12-05 15:00:00
资讯
新帖
简况
每周股票复盘：春立医疗（688236）H股类别股东大会延期至12月3日
证券之星 · 11-23
每周股票复盘：春立医疗（688236）H股类别股东大会延期至12月3日
11月21日春立医疗跌5.18%，融通医疗保健行业混合A/B基金重仓该股
证券之星 · 11-21
11月21日春立医疗跌5.18%，融通医疗保健行业混合A/B基金重仓该股
春立医疗（688236）公司公告H股类别股东大会延期，11月18日股价下跌1.56%
证券之星 · 11-18
春立医疗（688236）公司公告H股类别股东大会延期，11月18日股价下跌1.56%
每周股票复盘：春立医疗（688236）订立790百万元结构性存款协议
证券之星 · 11-16
每周股票复盘：春立医疗（688236）订立790百万元结构性存款协议
春立医疗新注册《春立医疗数字化正畸服务平台V1.0》项目的软件著作权
证券之星 · 11-14
春立医疗新注册《春立医疗数字化正畸服务平台V1.0》项目的软件著作权
春立医疗(01858)认购合共7.9亿元北京银行结构性存款产品
智通财经 · 11-11
春立医疗(01858)认购合共7.9亿元北京银行结构性存款产品
11月10日春立医疗涨5.18%，融通医疗保健行业混合A/B基金重仓该股
证券之星 · 11-10
11月10日春立医疗涨5.18%，融通医疗保健行业混合A/B基金重仓该股
春立医疗涨5.18%，华安证券二个月前给出“买入”评级
证券之星 · 11-10
春立医疗涨5.18%，华安证券二个月前给出“买入”评级
春立医疗盘中涨超9% 华泰证券维持“买入”评级
新浪港股 · 11-03
春立医疗盘中涨超9% 华泰证券维持“买入”评级
港股异动 | 春立医疗(01858)再涨超9% 海外业务已成为重要收入来源 三季度业绩同比高速增长
智通财经 · 11-03
港股异动 | 春立医疗(01858)再涨超9% 海外业务已成为重要收入来源 三季度业绩同比高速增长
集采影响消散年内股价涨超120%，横盘三个月的春立医疗(01858)将走向何方？
智通财经 · 11-02
集采影响消散年内股价涨超120%，横盘三个月的春立医疗(01858)将走向何方？
每周股票复盘：春立医疗（688236）Q3净利同比增531.12%
证券之星 · 11-02
每周股票复盘：春立医疗（688236）Q3净利同比增531.12%
春立医疗（688236）2025年三季报简析：营收净利润同比双双增长，公司应收账款体量较大
证券之星 · 11-01
春立医疗（688236）2025年三季报简析：营收净利润同比双双增长，公司应收账款体量较大
图解春立医疗三季报：第三季度单季净利润同比增长531.12%
证券之星 · 10-30
图解春立医疗三季报：第三季度单季净利润同比增长531.12%
每周股票复盘：春立医疗（688236）股本无变动
证券之星 · 09-07
每周股票复盘：春立医疗（688236）股本无变动
港股异动 | 春立医疗(01858)午前涨超7% 上半年医疗器械企业加速海外布局 公司出口业务持续攀升
智通财经 · 09-03
港股异动 | 春立医疗(01858)午前涨超7% 上半年医疗器械企业加速海外布局 公司出口业务持续攀升
华安证券：给予春立医疗买入评级
证券之星 · 09-02
华安证券：给予春立医疗买入评级
港股异动 | 春立医疗(01858)涨超12% 公司上半年归母净利同比增长44.85%
智通财经 · 09-01
港股异动 | 春立医疗(01858)涨超12% 公司上半年归母净利同比增长44.85%
每周股票复盘：春立医疗（688236）Q2归母净利润同比增136.7%
证券之星 · 08-31
每周股票复盘：春立医疗（688236）Q2归母净利润同比增136.7%
春立医疗（688236）2025年中报简析：营收净利润同比双双增长，公司应收账款体量较大
证券之星 · 08-31
春立医疗（688236）2025年中报简析：营收净利润同比双双增长，公司应收账款体量较大
加载更多
公司概况
公司名称：
北京市春立正达医疗器械股份有限公司
所属行业：
专用设备制造业
上市日期：
2021-12-30
主营业务：
北京市春立正达医疗器械股份有限公司的主营业务是植入性骨科医疗器械的研发、生产与销售。公司的主要产品是脊柱类、创伤类、关节类、运动医学类、骨修复材料类植入物、手术器械产品、富血小板血浆（PRP）制备用套装、封闭创伤负压引流套装。公司是国家工信部认定的人工关节假体制造业单项冠军企业。
发行价格：
29.81
{"stockData":{"symbol":"688236","market":"SH","secType":"STK","nameCN":"春立医疗","latestPrice":24.27,"timestamp":1764918000000,"preClose":24.21,"halted":0,"volume":844197,"delay":0,"changeRate":0.0025,"floatShares":288000000,"shares":384000000,"eps":0.6658,"marketStatus":"已收盘","change":0.06,"latestTime":"12-05 15:00:00","open":24.05,"high":24.4,"low":23.82,"amount":20379700,"amplitude":0.024,"askPrice":24.27,"askSize":11,"bidPrice":24.25,"bidSize":86,"shortable":0,"etf":0,"ttmEps":0.6658,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":5,"adr":0,"adjPreClose":24.21,"symbolType":"stock_kcb","openAndCloseTimeList":[[1764898200000,1764905400000],[1764910800000,1764918000000]],"highLimit":26.63,"lowLimit":21.79,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":383568500,"isCdr":false,"pbRate":3.12,"roa":"--","peRate":36.452388,"roe":"6.6%","epsLYR":0.33,"committee":0.08502,"marketValue":9309000000,"turnoverRate":0.0029,"status":0,"afterMarket":{"amount":0,"volume":0,"close":24.27,"buyVolume":0,"sellVolume":0,"time":1764920037768,"indexStatus":"已收盘 12-05 15:30:00","preClose":24.21},"hkstockBrief":{"symbol":"01858","market":"HK","secType":"STK","nameCN":"春立医疗","latestPrice":16.2,"timestamp":1764922148004,"preClose":16.41,"halted":0,"volume":409250,"delay":0,"premium":"-39.39"},"floatMarketCap":7000000000},"requestUrl":"/m/hq/s/688236","defaultTab":"news","newsList":[{"id":"2585058901","title":"每周股票复盘：春立医疗（688236）H股类别股东大会延期至12月3日","url":"https://stock-news.laohu8.com/highlight/detail?id=2585058901","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585058901?lang=zh_cn&edition=full","pubTime":"2025-11-23 03:17","pubTimestamp":1763839031,"startTime":"0","endTime":"0","summary":"公司公告汇总由于拟出席H股类别股东大会的H股持有人所持附投票权的H股数目未达到公司组织章程细则规定的法定要求，原定于2025年11月19日召开的H股类别股东大会将延期至2025年12月3日上午十时正举行，会议地点不变。涉及取消监事会及相关章程修订的议案尚需经2025年第二次H股类别股东大会审议通过后方可生效。因H股类别股东大会未达到法定出席要求，会议已延期至2025年12月3日召开。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300000812.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK1100","688236","01858","BK1585"],"gpt_icon":0},{"id":"2585908141","title":"11月21日春立医疗跌5.18%，融通医疗保健行业混合A/B基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2585908141","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585908141?lang=zh_cn&edition=full","pubTime":"2025-11-21 15:45","pubTimestamp":1763711134,"startTime":"0","endTime":"0","summary":"证券之星消息，11月21日春立医疗跌5.18%，收盘报24.18元，换手率0.86%，成交量2.49万手，成交额6144.13万元。重仓春立医疗的公募基金请见下表：该股最近90天内共有10家机构给出评级，买入评级9家，增持评级1家；过去90天内机构目标均价为30.65。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共7家，其中持有数量最多的公募基金为融通基金的融通医疗保健行业混合A/B。该公募基金现任基金经理为万民远 刘曦阳。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100018683.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01858","BK0251","BK1585","BK1100","688236"],"gpt_icon":0},{"id":"2584555099","title":"春立医疗（688236）公司公告H股类别股东大会延期，11月18日股价下跌1.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584555099","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584555099?lang=zh_cn&edition=full","pubTime":"2025-11-18 22:28","pubTimestamp":1763476109,"startTime":"0","endTime":"0","summary":"截至2025年11月18日收盘，春立医疗报收于25.95元，较前一交易日下跌1.56%，最新总市值为99.54亿元。该股当日开盘26.36元，最高26.84元，最低25.91元，成交额达5054.39万元，换手率为0.67%。根据近日发布的公告，由于拟出席H股类别股东大会的H股持有人所持附投票权的H股数目未达到公司组织章程细则规定的法定要求，原定于2025年11月19日召开的H股类别股东大会将延期至2025年12月3日上午十时正举行，会议地点不变。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111800039999.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK1100","688236","01858","BK1585"],"gpt_icon":0},{"id":"2583065171","title":"每周股票复盘：春立医疗（688236）订立790百万元结构性存款协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2583065171","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583065171?lang=zh_cn&edition=full","pubTime":"2025-11-16 04:02","pubTimestamp":1763236937,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，春立医疗报收于27.48元，较上周的26.62元上涨3.23%。本周关注点公司公告汇总：春立医疗订立总金额为人民币790百万元的结构性存款产品协议。此前于2025年9月26日认购上海浦东发展银行结构性存款产品协议已赎回。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600001088.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688236","BK1100","BK0251","BK1585","01858"],"gpt_icon":0},{"id":"2583518249","title":"春立医疗新注册《春立医疗数字化正畸服务平台V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2583518249","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583518249?lang=zh_cn&edition=full","pubTime":"2025-11-14 01:58","pubTimestamp":1763056697,"startTime":"0","endTime":"0","summary":"证券之星消息，近日春立医疗新注册了《春立医疗数字化正畸服务平台V1.0》项目的软件著作权。今年以来春立医疗新注册软件著作权1个，较去年同期减少了80%。结合公司2025年中报财务数据，今年上半年公司在研发方面投入了5085.43万元，同比减24.84%。通过天眼查大数据分析，北京市春立正达医疗器械股份有限公司共对外投资了9家企业，参与招投标项目564次；财产线索方面有商标信息13条，专利信息1153条，著作权信息14条；此外企业还拥有行政许可166个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400000760.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1585","688236","BK1100","BK0251","01858"],"gpt_icon":0},{"id":"2582367044","title":"春立医疗(01858)认购合共7.9亿元北京银行结构性存款产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2582367044","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582367044?lang=zh_cn&edition=full","pubTime":"2025-11-11 22:44","pubTimestamp":1762872246,"startTime":"0","endTime":"0","summary":"此外，于2025年9月26日，公司订立上海浦东发展银行结构性存款产品协议，同意使用其内部资源认购上海浦东发展银行的结构性存款产品，总金额为人民币8500万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1368009.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0015","BK0183","SG9999006597.SGD","BK1585","BK0086","601169","BK0187","688236","BK0028","BK1100","BK0251","BK0012","BK0278","BK0188","01858","SGXZ49509284.SGD","SGXZ81163826.USD"],"gpt_icon":0},{"id":"2582082373","title":"11月10日春立医疗涨5.18%，融通医疗保健行业混合A/B基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2582082373","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582082373?lang=zh_cn&edition=full","pubTime":"2025-11-10 16:29","pubTimestamp":1762763362,"startTime":"0","endTime":"0","summary":"证券之星消息，11月10日春立医疗涨5.18%，收盘报28.0元，换手率1.28%，成交量3.69万手，成交额1.01亿元。重仓春立医疗的公募基金请见下表：该股最近90天内共有9家机构给出评级，买入评级8家，增持评级1家；过去90天内机构目标均价为30.65。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共7家，其中持有数量最多的公募基金为融通基金的融通医疗保健行业混合A/B。该公募基金现任基金经理为万民远 刘曦阳。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000020633.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688236","BK1100","BK1585","01858","BK0251"],"gpt_icon":0},{"id":"2582823758","title":"春立医疗涨5.18%，华安证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2582823758","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582823758?lang=zh_cn&edition=full","pubTime":"2025-11-10 16:29","pubTimestamp":1762763354,"startTime":"0","endTime":"0","summary":"今日春立医疗涨5.18%，收盘报28.0元。2025年9月2日，华安证券研究员谭国超,李婵发布了对春立医疗的研报《2025H1业绩高速增长，海外成为增长亮点》，该研报对春立医疗给出“买入”评级。研报中预计2025-2027年公司收入分别为11.39亿元、14.29亿元和17.75亿元，收入增速分别为41.3%、25.5%和24.3%，2025-2027年归母净利润分别实现2.41亿元、3.09亿元和3.90亿元，增速分别为92.8%、28.3%和26.1%，2025-2027年EPS预计分别为0.63元、0.81元和1.02元，对应2025-2027年的PE分别为36x、28x和22x，维持“买入”评级。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000020629.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688236","600909","01858"],"gpt_icon":0},{"id":"2580254952","title":"春立医疗盘中涨超9% 华泰证券维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2580254952","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580254952?lang=zh_cn&edition=full","pubTime":"2025-11-03 11:32","pubTimestamp":1762140720,"startTime":"0","endTime":"0","summary":" 春立医疗盘中涨超9%，绩后累涨近25%。截至发稿，股价上涨7.87%，现报20.42港元，成交额1.25亿港元。 春立医疗近期发布业绩，前三季度营业收入7.56亿元，同比增长48.75%；净利润1.92亿元，同比增长213.21%。 华泰证券认为，三季度业绩同比高速增长主因公司稳步推进国际市场开拓、出口业务收入持续攀升，且集采产品销量增长，看好后续海外收入持续快速增长，维持“买入”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-11-03/doc-infwaxxp5631430.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688236","01858","06886"],"gpt_icon":0},{"id":"2580125961","title":"港股异动 | 春立医疗(01858)再涨超9% 海外业务已成为重要收入来源 三季度业绩同比高速增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2580125961","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580125961?lang=zh_cn&edition=full","pubTime":"2025-11-03 10:29","pubTimestamp":1762136998,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，春立医疗再涨超9%，绩后累涨近25%。截至发稿，涨7.98%，报20.44港元，成交额9829.15万港元。消息面上，春立医疗近期发布业绩，前三季度营业收入7.56亿元，同比增长48.75%；净利润1.92亿元，同比增长213.21%。第三季度营业收入为2.68亿元，同比增长109.51%；归母净利润7706.19万元，同比实现扭亏为盈。该行指出，公司积极开拓国际市场业务，海外收入高速增长，已成为重要收入来源。海外业务持续拓展，看好25年海外业绩保持快速增长。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1364283.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","BK1100","688236","01858","BK1585"],"gpt_icon":0},{"id":"2580859942","title":"集采影响消散年内股价涨超120%，横盘三个月的春立医疗(01858)将走向何方？","url":"https://stock-news.laohu8.com/highlight/detail?id=2580859942","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580859942?lang=zh_cn&edition=full","pubTime":"2025-11-02 19:08","pubTimestamp":1762081691,"startTime":"0","endTime":"0","summary":"智通财经APP了解到，近日，春立医疗发布了其2025年前三季度业绩。财报显示，公司当期取得营业收入7.56亿元，同比增长48.75%;归属于上市公司股东的净利润1.92亿元，同比大幅增长213.21%。随着集采对公司影响逐渐消退，盈利能力回升的春立医疗也重新获得了二级市场的认可。此时春立医疗场内的筹码平均成本已拉升至15.88港元。今年上半年，春立医疗的海外收入占比已达4成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1364159.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1585","01858","BK0251","BK1100","688236"],"gpt_icon":0},{"id":"2580547291","title":"每周股票复盘：春立医疗（688236）Q3净利同比增531.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580547291","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580547291?lang=zh_cn&edition=full","pubTime":"2025-11-02 06:47","pubTimestamp":1762037229,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，春立医疗报收于28.88元，较上周的26.0元上涨11.08%。本周关注点来自业绩披露要点：2025年第三季度归母净利润7706.19万元，同比上升531.12%。股本股东变化截至2025年9月30日，公司股东户数为6149户，较6月30日增加243户，增幅4.11%。报告期末普通股股东总数为6164户，其中A股6149户，H股15户。公司公告汇总公司发布2025年第三季度报告，前三季度营收7.56亿元，归母净利润1.92亿元，同比增长213.21%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200001410.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688236","BK0251","BK1100","01858","BK1585"],"gpt_icon":0},{"id":"2580329417","title":"春立医疗（688236）2025年三季报简析：营收净利润同比双双增长，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2580329417","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580329417?lang=zh_cn&edition=full","pubTime":"2025-11-01 06:49","pubTimestamp":1761950965,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期春立医疗发布2025年三季报。截至本报告期末，公司营业总收入7.56亿元，同比上升48.75%，归母净利润1.92亿元，同比上升213.21%。本报告期春立医疗公司应收账款体量较大，当期应收账款占最新年报归母净利润比达223.1%。然而去年的净利率为15.47%，算上全部成本后，公司产品或服务的附加值高。财报体检工具显示：建议关注公司应收账款状况分析师工具显示：证券研究员普遍预期2025年业绩在2.41亿元，每股收益均值在0.63元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110100007867.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01858","688236"],"gpt_icon":0},{"id":"2579272149","title":"图解春立医疗三季报：第三季度单季净利润同比增长531.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579272149","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579272149?lang=zh_cn&edition=full","pubTime":"2025-10-30 20:21","pubTimestamp":1761826884,"startTime":"0","endTime":"0","summary":"证券之星消息，春立医疗2025年三季报显示，前三季度公司主营收入7.56亿元，同比上升48.75%；归母净利润1.92亿元，同比上升213.21%；扣非净利润1.81亿元，同比上升311.07%；其中2025年第三季度，公司单季度主营收入2.68亿元，同比上升109.51%；单季度归母净利润7706.19万元，同比上升531.12%；单季度扣非净利润7451.86万元，同比上升439.4%；负债率15.65%，投资收益321.7万元，财务费用-972.34万元，毛利率67.27%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000040995.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01858","688236"],"gpt_icon":0},{"id":"2565954560","title":"每周股票复盘：春立医疗（688236）股本无变动","url":"https://stock-news.laohu8.com/highlight/detail?id=2565954560","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565954560?lang=zh_cn&edition=full","pubTime":"2025-09-07 06:24","pubTimestamp":1757197454,"startTime":"0","endTime":"0","summary":"截至2025年9月5日收盘，春立医疗报收于23.45元，较上周的22.35元上涨4.92%。本周，春立医疗9月1日盘中最高价报24.08元。春立医疗当前最新总市值89.95亿元，在医疗器械板块市值排名40/126，在两市A股市值排名2017/5152。本周关注点公司公告汇总：截至2025年8月31日，春立医疗H股和A股股本均无变动。A股于上海证券交易所上市，证券代号688236，上月底结存及本月底结存均为288,428,000股，面值人民币1元，法定股本为人民币288,428,000元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090700001331.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1100","BK0251","BK1585","01858","688236"],"gpt_icon":0},{"id":"2564356640","title":"港股异动 | 春立医疗(01858)午前涨超7% 上半年医疗器械企业加速海外布局 公司出口业务持续攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=2564356640","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564356640?lang=zh_cn&edition=full","pubTime":"2025-09-03 11:47","pubTimestamp":1756871252,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，春立医疗午前涨超7%，截至发稿，涨7.16%，报17.06港元，成交额6813.31万港元。消息面上，近日，春立医疗公布2025年中期业绩，营业收入约4.88亿元，同比增长28.27%；归属于上市公司股东的净利润约1.14亿元，同比增长44.85%。公告指出，收入增长主要是期内稳定供应集采产品，销量持续增长。另外公司稳步推进国际市场的开拓工作，出口业务持续攀升。国金证券指出，2025年上半年国内医疗设备招标需求已呈现恢复趋势，预计下半年业绩有望逐步修复。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1340885.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","159883","BK1100","BK1222","BK0251","BK1574","01858","BK1585","09996","09997","688236"],"gpt_icon":0},{"id":"2564205768","title":"华安证券：给予春立医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2564205768","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564205768?lang=zh_cn&edition=full","pubTime":"2025-09-02 12:22","pubTimestamp":1756786944,"startTime":"0","endTime":"0","summary":"华安证券股份有限公司谭国超,李婵近期对春立医疗进行研究并发布了研究报告《2025H1业绩高速增长，海外成为增长亮点》，给予春立医疗买入评级。 春立医疗 主要观点： 事件： 公司发布2025年中报。收入增长主要系报告期内稳定供应集采产品，销量持续增长。 风险提示 公司手术量增长不及预期风险。最新盈利预测明细如下：该股最近90天内共有2家机构给出评级，买入评级2家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090200017778.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01858","600909","688236"],"gpt_icon":0},{"id":"2564613018","title":"港股异动 | 春立医疗(01858)涨超12% 公司上半年归母净利同比增长44.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2564613018","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564613018?lang=zh_cn&edition=full","pubTime":"2025-09-01 09:40","pubTimestamp":1756690804,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，春立医疗(01858)涨超12%，截至发稿，涨12.17%，报16.68港元，成交额2142.66万港元。消息面上，春立医疗公布2025年中期业绩，营业收入约4.88亿元，同比增长28.27%；归属于上市公司股东的净利润约1.14亿元，同比增长44.85%。公告指出，收入增长主要是期内稳定供应集采产品，销量持续增长。另外公司稳步推进国际市场的开拓工作，出口业务持续攀升。净利增长则主要归因于期内公司稳定供应集采产品、深度拓展国际市场，推动销量增长；同时内部降本增效，强化核心业务竞争力，内外并举推动盈利能力稳步提升，实现了净利润的持续增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1339714.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1585","688236","BK0251","BK1100","01858"],"gpt_icon":0},{"id":"2563783439","title":"每周股票复盘：春立医疗（688236）Q2归母净利润同比增136.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563783439","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563783439?lang=zh_cn&edition=full","pubTime":"2025-08-31 13:33","pubTimestamp":1756618388,"startTime":"0","endTime":"0","summary":"截至2025年8月29日收盘，春立医疗报收于22.35元，较上周的22.67元下跌1.41%。本周，春立医疗8月26日盘中最高价报23.17元。本周关注点业绩披露要点：2025年第二季度归母净利润5639.84万元，同比上升136.7%。股本股东变化股东户数变动截至2025年6月30日，春立医疗股东户数为5906.0户，较3月31日减少1261.0户，减幅17.59%。营业收入4.88亿元，同比增28.27%；归母净利润1.14亿元，同比增44.85%；扣非净利润1.06亿元，同比增61.09%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083100004676.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01858","688236"],"gpt_icon":0},{"id":"2563880415","title":"春立医疗（688236）2025年中报简析：营收净利润同比双双增长，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2563880415","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563880415?lang=zh_cn&edition=full","pubTime":"2025-08-31 06:16","pubTimestamp":1756592210,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期春立医疗发布2025年中报。截至本报告期末，公司营业总收入4.88亿元，同比上升28.27%，归母净利润1.14亿元，同比上升44.85%。本报告期春立医疗公司应收账款体量较大，当期应收账款占最新年报归母净利润比达210.15%。然而去年的净利率为15.47%，算上全部成本后，公司产品或服务的附加值高。财报体检工具显示：建议关注公司应收账款状况分析师工具显示：证券研究员普遍预期2025年业绩在2.22亿元，每股收益均值在0.58元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083100001604.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688236","01858"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765125957332,"stockEarnings":[{"period":"1week","weight":-0.0078},{"period":"1month","weight":-0.1197},{"period":"3month","weight":0.035},{"period":"6month","weight":0.4504},{"period":"1year","weight":0.6868},{"period":"ytd","weight":0.9003}],"compareEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":-0.0167},{"period":"3month","weight":0.0237},{"period":"6month","weight":0.1529},{"period":"1year","weight":0.1585},{"period":"ytd","weight":0.1644}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北京市春立正达医疗器械股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"6149人(较上一季度增加4.11%)","perCapita":"46906股","listingDate":"2021-12-30","address":"北京市通州区通州经济开发区南区鑫觅西二路10号","registeredCapital":"38356万元","survey":" 北京市春立正达医疗器械股份有限公司的主营业务是植入性骨科医疗器械的研发、生产与销售。公司的主要产品是脊柱类、创伤类、关节类、运动医学类、骨修复材料类植入物、手术器械产品、富血小板血浆（PRP）制备用套装、封闭创伤负压引流套装。公司是国家工信部认定的人工关节假体制造业单项冠军企业。","listedPrice":29.81},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"春立医疗(688236)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供春立医疗(688236)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"春立医疗,688236,春立医疗股票,春立医疗股票老虎,春立医疗股票老虎国际,春立医疗行情,春立医疗股票行情,春立医疗股价,春立医疗股市,春立医疗股票价格,春立医疗股票交易,春立医疗股票购买,春立医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"春立医疗(688236)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供春立医疗(688236)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}